Rebastinib (Compound)

Compound:

rebastinib (4586c36d-507e-4fa9-9953-d3b793214d2b)

Synonyms:REBASTINIB, 1020172-07-9, DCC-2036, DCC-2036 (Rebastinib), DCC 2036, 4-(4-(3-(3-(tert-butyl)-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)-3-fluorophenoxy)-N-methylpicolinamide, Rebastinib [USAN], CHEBI:62166, MFCD19443646, N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea

Pubchem:PUBCHEM:25066467

Id:91391355-9c80-51f9-af7e-8bba7ffa09eb

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Rebastinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Rebastinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Rebastinib.

Results found

Linked to

	Label	Description
	BRD-K76694128-001-04-3 Substance (Entity type)	A Substance
	Rebastinib positively regulates CD44 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rebastinib negatively regulates SLPI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rebastinib negatively regulates INSR Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rebastinib positively regulates ARL6IP5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rebastinib negatively regulates KRT15 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rebastinib negatively regulates AMDHD2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rebastinib positively regulates SFRP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rebastinib positively regulates CD99 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rebastinib positively regulates LCP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K76694128-001-04-3

Substance (Entity type)

A Substance

Rebastinib positively regulates CD44

Knowledge Graph Assertion (Entity type)